Sign inJoin waitlistJoin the waitlist

Christopher Darus

, Associate Member · Providence Health & Services - Oregon

Credentials: · · · · · · · ·

History

Salem Health Hospitals and Clinics
2024–Present

Cleveland Clinic
2007–2011
Gynecologic Oncology
University of Virginia Medical Center
2004–2007
University of Colorado School of Medicine
2000–2003
Boonshoft School of Medicine - Wright State University
1996–2000

Research

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
Journal of Clinical Oncology · 2021 · 336 citations
The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors
The American Journal of Surgical Pathology · 2008 · 94 citations
Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation
Molecular Endocrinology · 1996 · 83 citations

CA
Carol Aghajanian
4 papers
David Bender
4 papers
LR
Laurel Rice
4 papers
Robert Mannel
4 papers
Amir Jazaeri
3 papers
Kathleen Moore
3 papers
BS
Bernard Schneider
2 papers
GS
Gregory Sutton
2 papers
Jason Lachance
2 papers · 2 as a fellow
JC
Jay Carlson
2 papers
JS
Jeanne Schilder
2 papers
Susan Modesitt
2 papers

Grants

MaineHealth Cancer Care Network (MHCCN) and NCORP Activities Across the Lifespan
National Cancer Institute · UG1
PI · $855.9K · Mainehealth
2019–2025

Clinical trials

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2031
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Site PI · Recruiting · Phase 3
Imunon
2025–2032
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Site PI · Recruiting · Phase 1
GlaxoSmithKline
2024–2029
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Site PI · Recruiting
GOG Foundation
2022–2030